Antitumor effect of the cinnamaldehyde derivative CB403 through the arrest of cell cycle progression in the G2/M phase

Biochemical Pharmacology

Volumn 65, Issue 8, 2003, Pages 1343-1350

  Jeong, Ha Won ^a   Han, Dong Cho ^a   Son, Kwang Hee ^a   Han, Mi Young ^a   Lim, Jong Seok ^a   Ha, Ji Hong ^b   Lee, Chang Woo ^a   Kim, Hwan Mook ^a   Kim, Hyoung Chin ^a   Kwon, Byoung Mog ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

Antitumor; Cell cycle; Cinnamaldehyde; Cyclin

Indexed keywords

CB 403; CINNAMALDEHYDE DERIVATIVE; CYCLIN B1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; BREAST TUMOR; CANCER CELL CULTURE; CANCER INHIBITION; CELL ADHESION; CELL ASSAY; CELL CYCLE G2 PHASE; CELL STRAIN MCF 7; COLON TUMOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG INHIBITION; DRUG SYNTHESIS; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IN VIVO STUDY; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR XENOGRAFT;

EID: 0037446268     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00038-8     Document Type: Article

References (17)

1. Fussenegger M., Bailey J.E. Molecular regulation of cell-cycle progression and apoptosis in mammalian cells: implications for biotechnology. Biotechnol. Prog. 14:1998;807-833.
2. Elledge S.J. Cell cycle checkpoints: preventing an identity crisis. Science. 274:1996;1664-1672.
3. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677.
4. 1-phase progression. Genes Dev. 13:1999;1501-1512.
5. Kwon B.M., Cho Y.K., Lee S.H., Nam J.Y., Bok S.H., Chun S.K., Kim J.A., Lee I.R. 2-Hydroxycinnamaldehyde from stem bark of Cinnamomum cassia. Planta Med. 62:1996;183-184.
6. Koh W.S., Yoon S.Y., Kwon B.M., Jeong T.C., Nam K.S., Han M.Y. Cinnamaldehydes inhibit lymphocyte proliferation and modulate T cell differentiation. Int. J. Immunopharmacol. 20:1998;643-660.
7. Kwon B.M., Lee S.H., Cho Y.K., Bok S.H., So S.H., Youn M.R., Chang S.I. Synthesis and biological activity of cinnamaldehydes as angiogenesis inhibitors. Bioorg. Med. Chem. Lett. 7:1997;2473-2476.
8. Lee C.W., Hong D.H., Han S.B., Park S.H., Kim H.K., Kwon B.M., Kim H.M. Inhibition of human tumor growth by 2′-hydroxy- and 2′-benzoyloxycinnamaldehydes. Planta Med. 65:1999;263-266.
9. Jeong H.W., Kim M.R., Son K.H., Han M.Y., Ha J.H., Garnier M., Meijer L., Kwon B.M. Cinnamaldehydes inhibit cyclin dependent kinase 4/cyclin D1. Bioorg. Med. Chem. Lett. 10:2000;1819-1822.
10. Jin P., Hardy S., Morgan D.O. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J. Cell Biol. 141:1998;875-885.
11. Sun J., Qian Y., Hamilton A.D., Sebti S.M. Both farnesyltransferase and geranylgeranyl-transferase I inhibitors are required for inhibition of oncogenic K-Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts. Oncogene. 16:1998;1467-1473.
12. Mitscher L.A., Telikepalli H., Wang P.B., Kuo S., Shankel D.M., Stewart G. Antimutagenicity of secondary metabolites from higher plants. Mutat. Res. 267:1992;229-241.
13. Hunt T., Luca F.C., Ruderman J.V. The requirements for protein synthesis and degradation, and control of destruction of cyclins A and B in the meiotic and mitotic cell cycles of the clam embryo. J. Cell Biol. 116:1992;707-724.
14. Glotzeer M., Murray A.W., Kirschner M.W. Cyclin is degraded by the ubiquitin pathway. Nature. 349:1991;132-138.
15. Murray A. Cyclin ubiquitination: the destructive end of mitosis. Cell. 81:1995;149-152.
16. cdc2 kinase during mitosis. Nature. 349:1991;169-172.
17. Zhang Z., Vouri K., Wang H.G., Reed J.C., Ruoslahti E. Integrin activation by R-ras. Cell. 85:1996;61-69.